SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending amid increased discussion of potential collaborations with ExxonMobil on carbon capture technology for data centers, sparked by a recent conference call. The community is focused on interpreting statements made during the call and the potential impact of any partnership on FCEL's future prospects, especially when compared to sector peers. Interest is also fueled by the rising demand for clean energy solutions to power AI.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending due to a recent volume spike and increased attention on its micro float. Community members are discussing the potential for a significant price increase, drawing comparisons to other low-float stocks that have experienced parabolic runs. The stock's recent price action and the possibility of a squeeze are also key talking points.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending due to the appointment of a new CFO from Johnson & Johnson, sparking optimism about the company's future financial strategies. Community members are actively discussing the potential impact on the company's valuation and long-term prospects, especially with upcoming earnings and existing discussions of Medicare coverage for XPHOZAH.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is trending after reporting earnings that beat expectations and raising its full-year outlook, triggering multiple analyst upgrades and target price increases. The community is buzzing about the company's growth potential in AI, cybersecurity, and crypto, with some viewing it as a future "magnificent seven" stock. Discussions also highlight Cloudflare's move to enable website owners to monetize AI bot crawler access, sparking debate about the future of content creation and intellectual property.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Recent community discussion around MNKD centers on Oppenheimer's raised price target and speculation regarding a potential deal with Dexcom and pediatric approval for Afrezza. Increased trading volume has some investors suggesting a possible short squeeze. Others express concern about the company's performance and CEO, citing past failures and the need for new catalysts.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as traders assess market volatility amid mixed signals, including concerns about potential pullbacks and upcoming earnings reports from major tech companies. Community discussions revolve around hedging strategies and interpreting market indicators, with some anticipating a possible market correction or a volatility spike due to geopolitical tensions or economic uncertainty. The potential impact of upcoming economic data and policy decisions on market stability is also a key focus.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx is trending following recent earnings and forward guidance, with community members weighing in on the impact of cost-cutting measures, potential benefits from shifting business from competitors like UPS, and concerns regarding global trade and tariffs. Bullish sentiment is building as some anticipate a rally toward higher price targets, while others remain cautious due to potential headwinds and the company's historical performance. Option flow and unusual trading activity are also being closely monitored for directional cues.

Etsy, Inc. engages in the operation of an online marketplace. It offers handmade products such as shoes, clothing, bags, and accessories. It operates through the following segments: Etsy, Reverb, and Depop. The company was founded in 2005 and is headquartered in New York, NY.

Etsy Inc

Etsy is trending due to recent volatility following mixed reactions to earnings, a CEO transition, and fluctuating analyst ratings. Community discussions revolve around whether the stock is oversold or poised for further decline, as well as its potential for AI-driven growth and a possible buyout.

Advisorshares Trust - AdvisorShares MSOS 2x Daily ETF

AdvisorShares MSOS Daily Leveraged ETF

MSOX is trending as traders discuss potential catalysts in the cannabis sector, including possible rescheduling and the influence of political figures like Trump and RFK. Community sentiment appears mixed, with some expressing frustration over the ETF's performance and others anticipating a significant upswing. Discussions also highlight the complexities of the cannabis market and the potential impact of regulatory changes.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

DASH is trending as community members discuss its potential to catch up with other privacy coins like ZEC and XMR, with some anticipating a significant price increase. Traders are actively watching for a breakout above a key resistance level, which they believe could trigger an explosive move. Some users are pointing to the coin's limited supply relative to Bitcoin.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call

TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (TriSalus or the Company), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients...

TriSalus Life Sciences to Participate in Upcoming September Investor Conferences

TriSalus Life Sciences Inc. (Nasdaq: TLSI) (TriSalus or the Company), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients...

TriSalus Life Sciences, Inc. (TLSI) Reports Q2 Loss, Tops Revenue Estimates

TriSalus Life Sciences, Inc. (TLSI) delivered earnings and revenue surprises of -22.73% and +5.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo (MYO) delivered earnings and revenue surprises of 0.00% and +6.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zimmer Biomet (ZBH) Beats Q2 Earnings and Revenue Estimates

Zimmer (ZBH) delivered earnings and revenue surprises of +4.55% and +1.59%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

TriSalus Life Sciences, Inc. (TLSI) Reports Q1 Loss, Lags Revenue Estimates

OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)

TriSalus Life Sciences Inc. (TLSI) shares were in the spotlight on Thursday morning after the company’s <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.trisaluslifesci.com/news-releases/news-release-details/trisalus-life-sciences-reports-q4-and-full-year-2024-financial">fourth-quarter</a> loss exceeded Wall Street projections, but revenue topped expectations.TriSalus reported a 44% jump in its fourth-quarter (Q4) revenue to $8.3 million, higher than an analyst estimate of $8.25 million, according to FinChat data.The company’s loss per share narrowed to $0.4, compared to $1.57 in the same quarter a year ago, but it was wider than the estimated loss of $0.32.TriSalus reaffirmed its previous guidance for 2025 and said it expects sales growth of over 50% and its gross margin to exceed 87%, higher than the 86% reported for 2024. &nbsp;The oncology-focused medical technology company also said that it expects to be earnings before interest, tax, depreciation, and amortization (EBITDA) positive this year and achieve positive cash flow by the second half, extending its total cash runaway beyond this year.The company ended 2024 with $8.5 million in cash and cash equivalents.Operating expenses are also expected to reduce over 20% owing to reductions in research and development costs.On Stocktwits, retail sentiment continued to trend in the ‘extremely bearish’ territory while message volume jumped from ‘low’ to ‘high’ over the past 24 hours.<figure class="image"><img style="aspect-ratio:649/151;" src="https://news.stocktwits-cdn.com/Screenshot_2025_03_27_at_11_02_29_AM_png_72bc5e484f.webp" alt="TLSI's Sentiment Meter and Message Volume as of 11:30 a.m. ET on March 27, 2025 | Source: Stocktwits" width="649" height="151"><figcaption>TLSI's Sentiment Meter and Message Volume as of 11:30 a.m. ET on March 27, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expressed optimism about the company’s guidance.<stembedurl>https://stocktwits.com/FE123/message/609391420</stembedurl>Another highlighted the company’s growth in revenue.<stembedurl>https://stocktwits.com/FE123/message/609361644</stembedurl><a href="https://stocktwits.com/symbol/TLSI">TLSI shares</a> gained by over 12% this year but are down by over 40% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/new-fortress-energy-sells-jamaican-assets-to-excelerate-energy/chJ2EtuRbE4">New Fortress Energy Sells Jamaican Assets, Operations To Excelerate Energy For $1.06B: Stock Tumbles But Retail Cheers The Deal</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

TriSalus Life Sciences’ Q4 Loss Exceeds Projections, Revenue Tops Estimates – Retail Stays Pessimistic

The company reaffirmed its previous guidance for 2025 and said it expects sales growth of over 50% and its gross margin to exceed 87%, higher than the 86% reported for 2024. 

Equity

TriSalus Life Sciences Announces Key Appointments to Board of Directors

TriSalus Life Sciences Inc. (Nasdaq: TLSI), a biomedical technology company seeking to transform outcomes for patients with solid tumors by integrating its innovative delivery technology with...

TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed

TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.

TriSalus Life Sciences Inc

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.15	--	--	N/A
Q2 '25	-$0.21	-$0.27	-30.19%	MISSED
Q1 '25	-$0.22	-$0.39	-77.56%	MISSED
Q4 '24	-$0.32	-$0.40	-26.02%	MISSED
Q3 '24	-$0.35	-$0.12	65.38%	BEAT

TLSI
TriSalus Life Sciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest TLSI News

TLSITriSalus Life Sciences Inc